{"id":"https://openalex.org/A5132812652","orcid":null,"observed_orcids":[],"display_name":"I. Dridi","raw_author_names":["I. Dridi","Ichrack Dridi"],"full_name":"I. Dridi","works_count":3,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5132812652","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I166928557","ror":"https://ror.org/00nhtcg76","display_name":"University of Monastir","country_code":"TN","type":"education","lineage":["https://openalex.org/I166928557"]},"years":[2026,2023]},{"institution":{"id":"https://openalex.org/I4210167430","ror":"https://ror.org/05t1yee64","display_name":"Hospital Fatuma Bourguiba Monastir","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210167430"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I166928557","ror":"https://ror.org/00nhtcg76","display_name":"University of Monastir","country_code":"TN","type":"education","lineage":["https://openalex.org/I166928557"]},{"id":"https://openalex.org/I4210167430","ror":"https://ror.org/05t1yee64","display_name":"Hospital Fatuma Bourguiba Monastir","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210167430"]}],"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","count":1,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","value":1.33e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","value":8.4e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","value":7e-06,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","value":5e-06,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8320000171661377},{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.6956545114517212},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.44837486743927},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.15755724906921387},{"id":"106131492","wikidata":"https://www.wikidata.org/wiki/Q3072260","display_name":"Filter (signal processing)","score":0.0}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2026,"works_count":2,"oa_works_count":0,"cited_by_count":0}],"display_name_alternatives":["I. Dridi","Ichrack Dridi"],"block_key":"i dridi","works_api_url":"https://api.openalex.org/works?filter=author.id:A5132812652","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5132812652","updated_date":"2026-11-16T12:53:42","created_date":"2023-11-26T00:00:00"}
